Related Experiment Videos
Complications associated with central venous catheters. A survey
1Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD.
Chest
|December 1, 1988
Summary
Central venous catheter complications are often due to healthcare professional technique, not device failure. Improved education and reporting systems are needed to better track issues like infection.
Area of Science:
- Medical Device Safety
- Healthcare Quality Improvement
Background:
- The Federal Food and Drug Administration (FDA) mandates reporting of medical device malfunctions causing serious harm.
- Central venous catheters (CVCs) are critical medical devices with potential for serious complications.
Purpose of the Study:
- To analyze complications associated with central venous catheters reported to the FDA.
- To identify the primary causes of these complications and inform potential improvements.
Main Methods:
- Retrospective analysis of FDA adverse event reports over a two-year period.
- Categorization of complications and their attributed causes (device, professional, patient, pathology).
Main Results:
- 170 central venous catheter complications were reported, including tissue perforation and loss of catheter integrity.
- Healthcare professional technique was the leading cause (55%), followed by device failure (12%).
- No infection-related complications were reported, suggesting underreporting or systemic issues.
Conclusions:
- Central venous catheter complications are predominantly linked to healthcare professional technique.
- Enhanced education on catheter application and improved adverse event reporting systems are crucial.
- Current reporting may not adequately capture infection-related complications.